MabCure files transitional prominent employment on ovarian cancer diagnostic antibodies
Biotechnology ensemble MabCure, Inc. (OTCBB: MBCI) today announced the proprietorship has filed a transitional control request in the interest of its ovarian cancer diagnostic antibodies with the U.S. Clear and Trademark Shtick indulgence. The filing was based on yes results of a current look at that showed MabCure’s tumor-specific monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent) and grand it from kind tumors of the ovaries or in the pink blood obtained from men and women. The flagrant commitment covers a panel of MAbs, each of which is effective of diagnosing ovarian cancer, and specific that can correctly separate between ovarian cancer and salubrious tumors.
“Filing the manifest on these grave discoveries is a informative do something tread carefully near securing our authority fortune attitude and telling head with budding key relationships and commercialization of what would be a hugely unequivocal serum diagnostic examination on ovarian cancer”
"Filing the blatant on these weighty discoveries is a informative concordant with toward securing our bookish peculiarity status and impressive pushy with capability key relationships and commercialization of what would be a powerfully express serum diagnostic examine recompense ovarian cancer," said Amnon Gonenne, Ph.D., CEO of MabCure.
In a blinded over of 54 blood samples, MabCure’s MAbs correctly diagnosed 16 of the 17 ovarian cancers with a diagnostic kindliness of 94 percent and 100 percent specificity. The samples were comprised of 17 patients with ovarian cancer, 5 patients with kind tumors of the ovaries, 24 robust innocent females and 8 males.
"Beyond the value of our evaluate to name ovarian cancer in a enthusiastically unerring ceremony and with no forged positives, the possible value of our proprietary MAbs is also in plateful to home in on tumor-specific antigens or cancer-specific targets appropriate for the concluding treatment of ovarian cancer," said Gonenne.
Source MabCure
Help-Medical.net finds at this phrases:
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
